Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 10 studies | 35% ± 14% | |
club cell | 9 studies | 42% ± 21% | |
endothelial cell | 9 studies | 25% ± 9% | |
type II pneumocyte | 8 studies | 37% ± 12% | |
basal cell | 8 studies | 39% ± 17% | |
secretory cell | 7 studies | 25% ± 8% | |
respiratory goblet cell | 6 studies | 38% ± 20% | |
endothelial cell of artery | 6 studies | 18% ± 3% | |
ciliated cell | 5 studies | 28% ± 10% | |
retinal pigment epithelial cell | 4 studies | 36% ± 9% | |
mesothelial cell | 4 studies | 32% ± 10% | |
type I pneumocyte | 3 studies | 23% ± 5% | |
ionocyte | 3 studies | 28% ± 2% | |
abnormal cell | 3 studies | 43% ± 21% | |
vein endothelial cell | 3 studies | 39% ± 23% | |
hepatocyte | 3 studies | 62% ± 7% | |
oligodendrocyte | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 28% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3718.58 | 89 / 89 | 99% | 184.79 | 891 / 901 |
intestine | 96% | 1202.18 | 925 / 966 | 96% | 74.52 | 504 / 527 |
esophagus | 94% | 848.16 | 1362 / 1445 | 96% | 84.28 | 176 / 183 |
thymus | 100% | 2757.20 | 652 / 653 | 90% | 205.30 | 544 / 605 |
liver | 100% | 2964.73 | 226 / 226 | 90% | 48.82 | 364 / 406 |
stomach | 98% | 1094.73 | 351 / 359 | 91% | 83.93 | 260 / 286 |
lung | 97% | 2047.16 | 561 / 578 | 90% | 103.31 | 1041 / 1155 |
pancreas | 97% | 1175.76 | 318 / 328 | 89% | 73.32 | 159 / 178 |
bladder | 100% | 1472.71 | 21 / 21 | 80% | 58.51 | 401 / 504 |
uterus | 98% | 971.27 | 167 / 170 | 75% | 35.11 | 345 / 459 |
skin | 100% | 2281.87 | 1805 / 1809 | 66% | 68.11 | 310 / 472 |
breast | 100% | 2907.02 | 459 / 459 | 26% | 11.83 | 293 / 1118 |
prostate | 98% | 1419.70 | 241 / 245 | 14% | 3.47 | 69 / 502 |
adipose | 100% | 2964.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1809.95 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 97% | 882.02 | 233 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 179.56 | 75 / 80 |
heart | 87% | 815.10 | 749 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 84% | 842.50 | 1118 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 25.09 | 30 / 45 |
ovary | 19% | 144.94 | 35 / 180 | 22% | 6.68 | 94 / 430 |
brain | 27% | 253.58 | 723 / 2642 | 7% | 6.56 | 46 / 705 |
adrenal gland | 3% | 35.41 | 7 / 258 | 6% | 1.48 | 13 / 230 |
lymph node | 0% | 0 | 0 / 0 | 7% | 1.42 | 2 / 29 |
peripheral blood | 0% | 2.47 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_1905098 | Biological process | negative regulation of guanyl-nucleotide exchange factor activity |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0031016 | Biological process | pancreas development |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0050918 | Biological process | positive chemotaxis |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0007275 | Biological process | multicellular organism development |
GO_0001889 | Biological process | liver development |
GO_0031116 | Biological process | positive regulation of microtubule polymerization |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0030182 | Biological process | neuron differentiation |
GO_2001028 | Biological process | positive regulation of endothelial cell chemotaxis |
GO_0070495 | Biological process | negative regulation of thrombin-activated receptor signaling pathway |
GO_0006909 | Biological process | phagocytosis |
GO_1901299 | Biological process | negative regulation of hydrogen peroxide-mediated programmed cell death |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0048012 | Biological process | hepatocyte growth factor receptor signaling pathway |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0001886 | Biological process | endothelial cell morphogenesis |
GO_0007399 | Biological process | nervous system development |
GO_0016477 | Biological process | cell migration |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0017154 | Molecular function | semaphorin receptor activity |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005008 | Molecular function | hepatocyte growth factor receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MET |
Protein name | Soluble MET variant 7 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) MET proto-oncogene, receptor tyrosine kinase Soluble MET variant 14 Soluble MET variant 6 Soluble MET variant 8 Soluble MET variant 15 MET proto-oncogene, receptor tyrosine kinase (Met proto-oncogene variant I) Soluble MET variant 5 MET protein Proto-oncogenic met protein Soluble MET variant 13 Soluble MET variant 9 Soluble MET variant 3 Soluble MET variant 1 Soluble MET variant 12 Soluble MET variant 11 Soluble MET variant 10 Soluble MET variant 2 |
Synonyms | |
Description | FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of neuronal precursors, angiogenesis and kidney formation. During skeletal muscle development, it is crucial for the migration of muscle progenitor cells and for the proliferation of secondary myoblasts (By similarity). In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis (By similarity). .; FUNCTION: (Microbial infection) Acts as a receptor for Listeria monocytogenes internalin InlB, mediating entry of the pathogen into cells. . |
Accessions | ENST00000454623.1 B5A942 B5A943 E6Y365 B5A937 B5A940 B5A936 B5A941 ENST00000436117.3 [P08581-3] C9JKM5 B5A929 B5A931 ENST00000397752.8 [P08581-1] P08581 B5A939 ENST00000422097.2 B5A938 ENST00000456159.1 H7C130 B5A935 Q14825 Q9UEJ3 B5A930 A0PJF7 ENST00000318493.11 [P08581-2] B5A934 B5A933 |